PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 171 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $682,228 | -90.7% | 40,901 | -84.5% | 0.00% | -100.0% |
Q2 2023 | $7,303,032 | +14.2% | 264,411 | -4.9% | 0.00% | 0.0% |
Q1 2023 | $6,392,528 | +1757.0% | 277,936 | +780.9% | 0.00% | – |
Q4 2022 | $344,232 | +42.2% | 31,552 | +9.8% | 0.00% | – |
Q3 2022 | $242,000 | +3.9% | 28,724 | -2.6% | 0.00% | – |
Q2 2022 | $233,000 | -67.2% | 29,503 | -1.7% | 0.00% | – |
Q1 2022 | $711,000 | +4.9% | 30,026 | +51.5% | 0.00% | – |
Q4 2021 | $678,000 | +70.4% | 19,825 | -11.7% | 0.00% | – |
Q3 2021 | $398,000 | -51.1% | 22,452 | +23.9% | 0.00% | – |
Q2 2021 | $814,000 | +210.7% | 18,122 | +79.4% | 0.00% | – |
Q1 2021 | $262,000 | -92.9% | 10,103 | -94.7% | 0.00% | -100.0% |
Q3 2020 | $3,699,000 | -10.6% | 189,232 | -19.2% | 0.00% | 0.0% |
Q2 2020 | $4,137,000 | +590.7% | 234,281 | +175.9% | 0.00% | – |
Q1 2020 | $599,000 | -21.6% | 84,930 | +33.4% | 0.00% | – |
Q3 2019 | $764,000 | -25.7% | 63,653 | -25.0% | 0.00% | – |
Q2 2019 | $1,028,000 | +14.7% | 84,849 | +19.0% | 0.00% | – |
Q1 2019 | $896,000 | +82.9% | 71,313 | -2.3% | 0.00% | – |
Q2 2018 | $490,000 | +1.2% | 72,964 | +29.6% | 0.00% | – |
Q1 2018 | $484,000 | – | 56,308 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |